Product Images Alendronate Sodium

This is a graph displaying the cumulative incidence of hip fractures over a 3-year study of FIT, focused on patients with radiographic vertebral fracture at baseline. On the x-axis there is a timeline displayed in months, and on the y-axis there is a percentage scale ranging from 0% to 12%. There are two lines plotted: one represents the placebo group, and the other represents the alendronate sodium group.*

Osteoporosis Treatment Studies have been conducted in postmenopausal women, comparing the effect of Alendronate Sodium 10 mg/day versus a placebo. The studies track the time course of the change in Lumbar Spine BMD (bone mineral density) in terms of percentage change from baseline. The data is presented in two sets: a US Study and a Multinational Study. The study duration is represented in months. Unfortunately, the text contains some gibberish characters making it difficult to interpret.*

This is a study comparing the effect of Alendronate Sodium 40mg/day vs placebo or Etidronate 400mg/day in patients with Paget's Disease of Bone. The study has a sample size of 27 or 47 individuals and investigates serum alkaline phosphatase levels over time. The results of the study are presented graphically using mean percent change from baseline with standard error bars.*

This is a description of Alendronate Sodium tablets, which is the generic drug for Fosamax. Each tablet contains 91 37mg of alendronate sodium thyrate. The recommended dose of the drug should be taken as directed and caution should be taken as it is prohibited by federal law to transfer the drug to any other person than the one it was prescribed to. The manufacturer is Cipla USA. The text also contains product numbers, lot numbers and insurance NDCs.*